eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Check drugs       Compare drugs       Join a support group

Review: taking Lamictal and Keppra Xr together

Summary: drug interactions are reported among people who take Lamictal and Keppra Xr together.

This review analyzes the effectiveness and drug interactions between Lamictal and Keppra Xr. It is created by eHealthMe based on reports of 3,431 people who take the same drugs from FDA and social media, and is updated regularly.

 

You are not alone: join a support group for people who take Lamictal and Keppra Xr >>>

On Feb, 26, 2015: 3,429 people who take Lamictal, Keppra Xr are studied

Lamictal, Keppra Xr outcomes

Drug combinations in study:
- Lamictal (lamotrigine)
- Keppra Xr (levetiracetam)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Lamictal is effective25.00%
(1 of 4 people)
44.44%
(4 of 9 people)
16.67%
(1 of 6 people)
50.00%
(7 of 14 people)
44.12%
(15 of 34 people)
53.85%
(14 of 26 people)
52.63%
(10 of 19 people)
33.33%
(1 of 3 people)
Keppra Xr is effective40.00%
(2 of 5 people)
66.67%
(6 of 9 people)
37.50%
(3 of 8 people)
25.00%
(4 of 16 people)
60.61%
(20 of 33 people)
72.00%
(18 of 25 people)
55.56%
(10 of 18 people)
33.33%
(1 of 3 people)

Drug effectiveness by gender :

FemaleMale
Lamictal is effective42.68%
(35 of 82 people)
54.55%
(18 of 33 people)
Keppra Xr is effective56.79%
(46 of 81 people)
51.43%
(18 of 35 people)

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Lamictal is effectiven/a0.00%
(0 of 2 people)
28.57%
(2 of 7 people)
27.66%
(13 of 47 people)
38.64%
(17 of 44 people)
45.45%
(5 of 11 people)
31.25%
(10 of 32 people)
50.00%
(6 of 12 people)
Keppra Xr is effectiven/a0.00%
(0 of 2 people)
42.86%
(3 of 7 people)
32.00%
(16 of 50 people)
45.45%
(20 of 44 people)
77.78%
(7 of 9 people)
35.29%
(12 of 34 people)
46.15%
(6 of 13 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
RashConvulsionPyrexiaDrug Exposure During PregnancyConvulsionRashFrostbiteConvulsion
ConvulsionPyrexiaDrug Exposure During PregnancyDiarrhoeaThermal BurnHypotensionDysphagiaDrug Exposure During Pregnancy
PyrexiaDepressionInsomniaInsomniaMood AlteredConvulsionConnective Tissue DisorderGrand Mal Convulsion
Stevens-johnson SyndromeHeadacheIrritabilityPyrexiaAggressionPulmonary EmbolismBlood Creatinine IncreasedFatigue
PruritusFallDiarrhoeaRespiratory DisorderPruritusDermatitis ExfoliativeHypokinesiaCondition Aggravated
Grand Mal ConvulsionThrombocytopeniaCoughEar CongestionThrombocytopeniaLaryngeal OedemaMusculoskeletal StiffnessRash
VomitingRashAtrial Septal DefectMotor Developmental DelayStevens-johnson SyndromeAgitationSclerodermaDizziness
Status EpilepticusDrug HypersensitivityMotor Developmental DelayUpper Respiratory Tract InfectionRashHypokalaemiaRhinalgiaDrug Ineffective
Drug IneffectiveDrug Exposure During PregnancyLivedo ReticularisRespiratory DistressRhabdomyolysisThrombosisPain In ExtremityNausea
Condition AggravatedDizzinessEar CongestionTachypnoeaOral DisorderBronchial ObstructionPainHeadache

Most common drug interactions by gender * :

FemaleMale
ConvulsionConvulsion
Drug Exposure During PregnancyGrand Mal Convulsion
Grand Mal ConvulsionFatigue
FatigueCondition Aggravated
HeadacheRash
DizzinessFall
NauseaStatus Epilepticus
RashAggression
Drug IneffectiveDepression
Condition AggravatedDizziness

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
Maternal Drugs Affecting FoetusConvulsionConvulsionConvulsionConvulsionConvulsionConvulsionConvulsion
Ventricular Septal DefectAggressionCondition AggravatedDrug Exposure During PregnancyDrug Exposure During PregnancyDizzinessFatigueConfusional State
Drug Exposure During PregnancyRashGrand Mal ConvulsionGrand Mal ConvulsionEpilepsyDrug IneffectiveHeadacheDizziness
Maternal Exposure During PregnancyCondition AggravatedDepressionNauseaNauseaGrand Mal ConvulsionUrinary Tract InfectionAsthenia
Foetal Exposure During PregnancyAbnormal BehaviourAggressionDrug IneffectiveGrand Mal ConvulsionHeadacheAstheniaNausea
Congenital HydronephrosisThrombocytopeniaThrombocytopeniaFatigueCondition AggravatedRashSomnolenceFall
Eyelid Ptosis CongenitalDrug IneffectiveEpilepsyVomitingHeadacheCondition AggravatedEpilepsyDepression
Oxygen Saturation DecreasedEncephalopathyRashDizzinessDizzinessFatigueDizzinessFatigue
Jaundice NeonatalHyperpyrexiaFatiguePregnancyFatigueSomnolenceConfusional StateTremor
Sudden DeathMetabolic AcidosisStevens-johnson SyndromeEpilepsyRashNauseaGrand Mal ConvulsionRash

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of Lamictal and Keppra Xr on

Do you take Lamictal and Keppra Xr?

 

 

 

You are not alone! Join a related mobile support group on :
- support group for people who take Keppra Xr
- support group for people who take Lamictal

Recent related drug studies (Check your drugs):

Complete drug side effects:

On eHealthMe, Lamictal (lamotrigine) is often used to treat bipolar disorder. Keppra Xr (levetiracetam) is often used to treat epilepsy. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.